Skip to main content
VSTM logo

Verastem, Inc.

VSTMNASDAQHealthcareBiotechnology

$10.06Today:- (-)1Y +28.81%

As of Oct 22, 2026 close

Market cap
$1.01B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.43$10.82
Volume (live)
-
Avg. volume (3M)
4.35M

Verastem (VSTM) Income Statement

Verastem reported revenue of $30.91M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 209.1% from $10.00M a year earlier. Verastem posted a net loss of $209.47M, compared with a net loss of $130.64M a year earlier. Gross margin was 82.9% and operating margin -550.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $40.08M, up 1775.4% from the same quarter a year earlier.

Verastem Income Statement Analysis

Values in millions USD

Scroll to see more
Verastem, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue30.9110.000.002.602.0588.5217.4626.720.00
Cost of Revenue5.300.000.000.000.0033.752.810.590.56
Gross Profit25.6210.000.002.602.0554.7714.6526.13-0.56
Operating Expenses
Research & Development114.6081.3361.3650.5639.3541.3845.7843.6546.42
Selling, General & Administrative81.1543.6230.7324.9824.1262.76101.2177.2721.38
Operating Expenses195.75124.9692.0875.5363.46104.13146.99120.9167.25
Operating Income-170.13-114.96-92.08-72.94-61.41-49.36-132.34-94.78-67.80
Other Income/Expense
Interest Income4.074.156.211.220.180.524.382.600.56
Interest Expense1.14-4.564.142.14-9.9715.7920.615.810.56
Other Income/Expense-42.27-15.504.720.05-9.79-18.17-16.8722.350.00
Income
Income Before Tax-209.47-130.45-87.37-73.81-71.20-67.53-149.21-72.43-67.80
Income Tax Expense0.000.190.000.000.000.190.000.000.00
Net Income-209.47-130.64-87.37-73.81-71.20-67.73-149.21-72.43-67.80
Net Income - Continuous Operations-209.47-130.64-87.37-73.81-71.20-67.73-149.21-72.43-67.80
Net Income - Discontinued Operations---------
EBITDA-207.61-114.93-83.17-71.56-61.20-50.48-126.42-65.21-66.69
EBIT-208.33-114.96-92.08-71.68-61.41-44.76---
Depreciation & Amortization0.730.030.060.120.211.262.181.420.56
Earnings Per Share
Basic EPS-3.00-4.00-4.00-5.00-5.00-5.00-24.00-13.00-21.00
Diluted EPS-3.00-4.00-4.00-5.00-5.00-5.00-24.00-16.00-21.00
Basic Shares Outstanding69.3135.7122.0516.1414.5412.786.215.783.20
Diluted Shares Outstanding69.3135.7122.0516.1414.5412.786.215.783.20

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Verastem Financial Statements

What was Verastem's revenue in fiscal 2025?

Verastem reported revenue of $30.91M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 209.1% from $10.00M a year earlier.

Is Verastem profitable?

No. Verastem reported a net loss of $209.47M in fiscal 2025. In fiscal 2024 it lost $130.64M.

What is Verastem's operating margin?

Verastem's operating income was −$170.13M on revenue of $30.91M in fiscal 2025, an operating margin of -550.3%, compared with -1149.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition